Clinical Trial Update: Study of Ondansetron in the Prevention of Sleep Syncope: The Nineth Prevention of Syncope Trial (POST9) [Phase 3]

View source ↗

Summary

This Phase 3 trial is evaluating ondansetron for prevention of sleep syncope, and is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sleep Syncope

Drugs mentioned

• Ondansetron (ondansetron)

Snippet

Sponsor: University of Calgary | Conditions: Sleep Syncope | Phase 3 | Status: NOT_YET_RECRUITING